HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aminoglutethimide (Cytadren)

An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
Also Known As:
Cytadren; Orimeten; 2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-
Networked: 502 relevant articles (36 outcomes, 79 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Siraki, Arno G: 3 articles (09/2015 - 07/2007)
2. Liu, Xian-Guo: 2 articles (01/2017 - 01/2016)
3. Wei, Xu-Hong: 2 articles (01/2017 - 01/2016)
4. Harvey, Philip W: 2 articles (01/2016 - 03/2003)
5. Michail, Karim: 2 articles (09/2015 - 07/2011)
6. Gnant, Michael: 2 articles (12/2007 - 03/2003)
7. Jakesz, Raimund: 2 articles (12/2007 - 03/2003)
8. Kubista, Ernst: 2 articles (12/2007 - 03/2003)
9. Kwasny, Werner: 2 articles (12/2007 - 03/2003)
10. Mlineritsch, Brigitte: 2 articles (12/2007 - 03/2003)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Cushing Syndrome
4. Carcinoma (Carcinomatosis)
5. Neoplasm Metastasis (Metastasis)

Related Drugs and Biologics

1. Tamoxifen
2. Hydrocortisone (Cortisol)
3. Hormones (Hormone)
4. Aminoglutethimide (Cytadren)
5. Metyrapone
6. Aromatase (CYP19)
7. Mitotane (Lysodren)
8. Aromatase Inhibitors
9. Medroxyprogesterone Acetate (Depo-Provera)
10. Megestrol Acetate (Borea)

Related Therapies and Procedures

1. Therapeutics
2. Adrenalectomy
3. Combination Drug Therapy (Combination Chemotherapy)
4. Radiotherapy
5. Hypophysectomy